Published in Lab Business Week, July 22nd, 2007
In this preclinical efficacy study, foals were treated with either ARCAD(TM) Instillate or control instillate. Results showed that animals treated with ARCAD(TM) Instillate had a 64% decrease in the number of adhesions and a 74% decrease in the severity of adhesions compared to control instillate. The investigators concluded that the use of ARCAD(TM) Instillate was well tolerated and effective in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.